Heparin-dependent regulation of fibronectin matrix conformation

Matrix Biology

Volumn 34, Issue , 2014, Pages 124-131

  Hubbard, Brant ^a   Buczek Thomas, Jo Ann ^b   Nugent, Matthew A ^b,c,d   Smith, Michael L ^c  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Boston University   (United States)

^d University of Massachusetts Lowell   (United States)

Author keywords

Extracellular matrix; Fibronectin; Heparin

Indexed keywords

FIBRONECTIN; HEPARAN SULFATE; HEPARIN; MONOCLONAL ANTIBODY; VASCULOTROPIN; ANTIBODY; PROTEIN BINDING;

ALLOSTERISM; ARTICLE; BINDING SITE; CELL FUNCTION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FORCE; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; REGULATORY MECHANISM; CELL ADHESION; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ANTIBODIES; BINDING SITES; CELL ADHESION; EXTRACELLULAR MATRIX; FIBRONECTINS; HEPARIN; HEPARITIN SULFATE; HUMANS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY;

EID: 84900307376     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.10.006     Document Type: Article

References (36)

1. Alexander S.S., Colonna G., Edelhoch H. The structure and stability of human plasma cold-insoluble globulin. J. Biol. Chem. 1979, 254:1501-1505.
2. Bradshaw M.J., Smith M.L. Contribution of unfolding and intermolecular architecture to fibronectin fiber extensibility. Biophys. J. 2011, 101:1740-1748.
3. Bradshaw M.J., Cheung M.C., Ehrlich D.J., Smith M.L. Using molecular mechanics to predict bulk material properties of fibronectin fibers. PLoS Comput. Biol. 2012, 8:e1002845.
4. Cao L., Zeller M.K., Fiore V.F., Strane P., Bermudez H., Barker T.H. Phage-based molecular probes that discriminate force-induced structural states of fibronectin in vivo. Proc. Natl. Acad. Sci. 2012, 109(19):7251-7256. (PNAS). U.S.A.
5. Chabria M., Hertig S., Smith M.L., Vogel V. Stretching fibronectin fibres disrupts binding of bacterial adhesins by physically destroying an epitope. Nat. Commun. 2010, 1:135.
6. Ejim O.S., Blunn G.W., Brown R.A. Production of artificial-orientated mats and strands from plasma fibronectin: a morphological study. Biomaterials 1993, 14:743-748.
7. Furue M.K., Na J., Jackson J.P., Okamoto T., Jones M., Baker D., Hata R., Moore H.D., Sato J.D., Andrews P.W. Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13409-13414.
8. Gold L.I., Frangione B., Pearlstein E. Biochemical and immunological characterization of three binding sites on human plasma fibronectin with different affinities for heparin. Biochemistry 1983, 22:4113-4119.
9. Grant R.P., Spitzfaden C., Altroff H., Campbell I.D., Mardon H.J. Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin. J. Biol. Chem. 1997, 272:6159-6166.
10. Hertig S., Chabria M., Vogel V. Engineering mechanosensitive multivalent receptor-ligand interactions: why the nanolinker regions of bacterial adhesins matter. Nano Lett. 2012, 12:5162-5168.
11. Hudalla G.A., Kouris N.A., Koepsel J.T., Ogle B.M., Murphy W.L. Harnessing endogenous growth factor activity modulates stem cell behavior. Integr. Biol. (Camb.) 2011, 3:832-842.
12. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219.
13. Khan M.Y., Medow M.S., Newman S.A. Unfolding transitions of fibronectin and its domains. Stabilization and structural alteration of the N-terminal domain by heparin. Biochem. J. 1990, 270:33-38.
14. Klein R.M., Zheng M., Ambesi A., Van De Water L., McKeown-Longo P.J. Stimulation of extracellular matrix remodeling by the first type III repeat in fibronectin. J. Cell Sci. 2003, 116:4663-4674.
15. Klotzsch E., Smith M.L., Kubow K.E., Muntwyler S., Little W.C., Beyeler F., Gourdon D., Nelson B.J., Vogel V. Fibronectin forms the most extensible biological fibers displaying switchable force-exposed cryptic binding sites. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:18267-18272.
16. Little W.C., Smith M.L., Ebneter U., Vogel V. Assay to mechanically tune and optically probe fibrillar fibronectin conformations from fully relaxed to breakage. Matrix Biol. 2008, 27:451-461.
17. Little W.C., Schwartlander R., Smith M.L., Gourdon D., Vogel V. Stretched extracellular matrix proteins turn fouling and are functionally rescued by the chaperones albumin and casein. Nano Lett. 2009, 9:4158-4167.
18. Martino M.M., Hubbell J.A. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J. 2010, 24:4711-4721.
19. Mitsi M., Hong Z., Costello C.E., Nugent M.A. Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry 2006, 45:10319-10328.
20. Mitsi M., Forsten-Williams K., Gopalakrishnan M., Nugent M.A. A catalytic role of heparin within the extracellular matrix. J. Biol. Chem. 2008, 283:34796-34807.
21. Molino P.J., Higgins M.J., Innis P.C., Kapsa R.M.I., Wallace G.G. Fibronectin and bovine serum albumin adsorption and conformational dynamics on inherently conducting polymers: a QCM-D study. Langmuir 2012, 28:8433-8445.
22. Pankov R., Yamada K.M. Fibronectin at a glance. J. Cell Sci. 2002, 115:3861-3863.
23. Sarrazin S., Lamanna W.C., Esko J.D. Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 2011, 3.
24. Sekiguchi K., Hakomori S., Funahashi M., Matsumoto I., Seno N. Binding of fibronectin and its proteolytic fragments to glycosaminoglycans. Exposure of cryptic glycosaminoglycan-binding domains upon limited proteolysis. J. Biol. Chem. 1983, 258:14359-14365.
25. Shi X., Zaia J. Organ-specific heparan sulfate structural phenotypes. J. Biol. Chem. 2009, 284:11806-11814.
26. Smith M.L., Gourdon D., Little W.C., Kubow K.E., Eguiluz R.A., Luna-Morris S., Vogel V. Force-induced unfolding of fibronectin in the extracellular matrix of living cells. PLoS Biol. 2007, 5:e268.
27. Smith E.M., Mitsi M., Nugent M.A., Symes K. PDGF-A interactions with fibronectin reveal a critical role for heparan sulfate in directed cell migration during Xenopus gastrulation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:21683-21688.
28. Symes K., Smith E.M., Mitsi M., Nugent M.A. Sweet cues: how heparan sulfate modification of fibronectin enables growth factor guided migration of embryonic cells. Cell Adh. Migr. 2010, 4:507-510.
29. Turnbull J., Powell A., Guimond S. Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol. 2001, 11:75-82.
30. Ugarova T.P., Zamarron C., Veklich Y., Bowditch R.D., Ginsberg M.H., Weisel J.W., Plow E.F. Conformational transitions in the cell binding domain of fibronectin. Biochemistry 1995, 34:4457-4466.
31. Underwood P.A., Dalton B.A., Steele J.G., Bennett F.A., Strike P. Anti-fibronectin antibodies that modify heparin binding and cell adhesion: evidence for a new cell binding site in the heparin binding region. J. Cell Sci. 1992, 102(Pt 4):833-845.
32. Underwood P.A., Steele J.G., Dalton B.A. Effects of polystyrene surface chemistry on the biological activity of solid phase fibronectin and vitronectin, analysed with monoclonal antibodies. J. Cell Sci. 1993, 104(Pt 3):793-803.
33. Vogel V., Sheetz M. Local force and geometry sensing regulate cell functions. Nat. Rev. Mol. Cell Biol. 2006, 7:265-275.
34. Wan A.M., Chandler E.M., Madhavan M., Infanger D.W., Ober C.K., Gourdon D., Malliaras G.G., Fischbach C. Fibronectin conformation regulates the proangiogenic capability of tumor-associated adipogenic stromal cells. Biochim. Biophys. Acta 2013, 1830(9):4314-4320.
35. Yamada K.M., Kennedy D.W., Kimata K., Pratt R.M. Characterization of fibronectin interactions with glycosaminoglycans and identification of active proteolytic fragments. J. Biol. Chem. 1980, 255:6055-6063.
36. Zhong C., Chrzanowska-Wodnicka M., Brown J., Shaub A., Belkin A.M., Burridge K. Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J. Cell Biol. 1998, 141:539-551.